$0.869200
0.044.85%
Pre-Market: Jul 19, 6:07 PM EDT
15 minutes delayed
TransCode Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TransCode Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RNAZ | TransCode Therapeutics | -$131.60 | -$0.58 | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
RNAZ | TransCode Therapeutics | -$259.07 | -$0.50 | -$0.65 | -30.00% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
RNAZ | TransCode Therapeutics | -$312.00 | -$10.80 | -$0.93 | 91.39% | $0.00 | — | $0.00 | — | 04/01/2024 | Get Alert |
RNAZ | TransCode Therapeutics | -$264.00 | -$43.60 | -$67.20 | -54.13% | $0.00 | — | $0.00 | — | 11/14/2023 | Get Alert |
RNAZ | TransCode Therapeutics | -$288.00 | -$135.60 | -$131.60 | 2.95% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
RNAZ | TransCode Therapeutics | -$216.00 | -$135.60 | -$264.00 | -94.69% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
RNAZ | TransCode Therapeutics | -$184.00 | -$304.00 | -$312.00 | -2.63% | $0.00 | — | $0.00 | — | 03/31/2023 | Get Alert |
RNAZ | TransCode Therapeutics | -$160.00 | — | -$264.00 | — | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
RNAZ | TransCode Therapeutics | $408.00 | — | -$288.00 | — | $0.00 | — | $0.00 | — | 08/15/2022 | Get Alert |
RNAZ | TransCode Therapeutics | -$776.00 | — | -$216.00 | — | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
RNAZ | TransCode Therapeutics | -$144.00 | — | -$184.00 | — | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
RNAZ | TransCode Therapeutics | -$240.00 | — | -$160.00 | — | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
RNAZ | TransCode Therapeutics | — | — | $408.00 | — | — | — | $0.00 | — | 08/23/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-0.65 | $-0.50 | -30.0 % |
Mar 2024 | 2024-04-01 | $-0.93 | $-10.80 | 91.4 % |
Sep 2023 | 2023-11-14 | $-67.20 | $-43.60 | -54.1 % |
Jun 2023 | 2023-08-14 | $-131.60 | $-135.60 | 2.95 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
TransCode Therapeutics (RNAZ) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
The Actual EPS was $-0.65, which missed the estimate of $-0.50.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.